Biogen (BIIB) Depreciation and Depletion (2018 - 2026)

Biogen (BIIB) has reported Depreciation and Depletion for 9 consecutive years, with $67.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation and Depletion fell 4.9% year-over-year to $67.9 million; the TTM figure through Mar 2026 stood at $269.3 million (down 6.75% YoY), while the FY2025 annual figure was $272.8 million, down 4.85% from the prior year.
• Depreciation and Depletion came in at $67.9 million for Q1 2026 at Biogen, roughly flat from $68.0 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $76.3 million in Q1 2022, with the low at $62.1 million in Q1 2023.
• Average Depreciation and Depletion over 5 years is $67.9 million, with a median of $67.2 million recorded in 2022.
• Across the five-year window, Depreciation and Depletion surged 56.35% in 2022 and decreased 18.61% in 2023, its largest moves.
• Year by year, Depreciation and Depletion stood at $64.7 million in 2022, then dropped by 1.85% to $63.5 million in 2023, then grew by 14.65% to $72.8 million in 2024, then retreated by 6.59% to $68.0 million in 2025, then dropped by 0.15% to $67.9 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $67.9 million, $68.0 million, and $66.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.